BRCA1/2 genetically interacts with the p53 pathway, at least partially explaining the so-called “BRCA paradox,” defined by BRCA-deficient tumor cells rapidly proliferating, while BRCA-deficient embryos suffer from proliferation defects [12] (for further detail see later). The gene discussed is TP53; the disease is neoplasm.